SEC Form D · filed November 15, 2022
Spero Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Tamara C. Joseph · Cambridge, MAExecPatrick E. Vink · Cambridge, MADirectorAnkit Mahadevia · Cambridge, MAExec · DirectorSatyavrat E. Shukla · Cambridge, MAExecMilind Deshpande · Cambridge, MADirectorFrank E. Thomas · Cambridge, MADirectorScott C. Jackson · Cambridge, MADirectorCynthia C. Smith · Cambridge, MADirectorTimothy C. Keutzer · Cambridge, MAExecDaniel Vitt · New York, NYExecLex Ferenda Litigation Funding LLC · Rye Brook, NYDirectorKevin S. Lavelle · Dallas, TXDirectorVivekanand Arza · San Jose, CAExecGlenn M. Whaley · New York, NYExec · DirectorInderpal M. Singh · New York, NYDirectorLex Ferenda Litigation Funding GP LLC · Rye Brook, NYDirectorJohn Wires · Shawnee, KSExecAndreas Muehler · New York, NYDirectorKamal C. Hamed · Cambridge, MAExecKathleen C. Tregoning · Cambridge, MADirectorJohn C. Pottage, Jr · Cambridge, MADirectorDaniel R. Karlin · DALLAS, TXDirectorJ. A. Antonelli · Provo, UTDirectorBarry D. Mower · Provo, UTDirectorRachel Kern · DALLAS, TXExecDeborah Jones · Raleigh, NCExecMatthew Hobbs · Raleigh, NCDirectorMichael Burt · Edinburgh, United KingdomExecAngus Burt · Edinburgh, United KingdomDirectorKevin D. Costello · Portland, MEExec · DirectorKamal C. Hamed · Cambridge, MAExecKathleen C. Tregoning · Cambridge, MADirectorJohn C. Pottage, Jr · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗